And so, at last we have a pill credible longevity.

It's called Basis (because it wants to provide the foundation for a long life) and is a dietary supplement that claims to increase your "metabolic health."
It was developed by Elysium Health, a research company that blends the infatuation of Silicon Valley for eternal life and the science of the East Coast: its founder and CEO, Eric Marcotulli, comes from a background in corporate capitalism Menlo Park, while the chief scientist Leonard Guarente conducts aging research at MIT since 1982, and was previously in charge of the project for the extension of life, Elixir.
While the stated objective of Elysium is "helping people to access, understand and have benefit from the advances of science in the field of health," a quick look at his blog shows that the company's intention is to "stop proverbial clock "of aging.
The development of 'yet another magic pill to sell online should not getting excited, but there is one small detail: Elysium boasts five Nobel prizes (two for chemistry, three for medicine) as consultants.
This thing is interesting for two reasons.
The first is that Basis will be labeled as a "dietary supplement," since Elysium has not carried out tests on men, which is necessary to sell it as a drug approved.
While the US market for supplements is 18 billion dollars annually, common medicine is critical of supplements and notes that the beneficial effects can not always be demonstrated.
Now five guys with the Nobel medals on the fireplace put their scientific weight behind a pill-using natural substances that can be found in milk (nicotinamide riboside) and blueberries (pterostilbene) -has prevented the metabolism of mice deteriorate , keeping them healthier longer.
To be sure, Basis is far from unassailable.
Says the Harvard biologist Pere Puigserver the Boston Globe: "It's not exactly clear what the goal of this pill.
What does improve the health of metabolism? "
He also pointed out that the integrator needs to be tested on humans before being considered of any value.
For its part, Elysium has promised to conduct tests on people as soon as possible, and to release the results to the public-even though it may take decades to obtain decisive evidence.
Even after that, Basis may still have difficulty receiving the stamp of approval of the FDA, because the authorities do not recognize aging as a disease by itself.
Still, if Elysium remains true to its stated principles of scientific rigor and transparency, it could become one of the first dealers supplements with some credibility.
Which brings us to another important topic Elysium is a research on longevity that sells a pill.
This type of research is underfunded in many aspects because investors may not see an immediate return on their investment: in general, the laboratories that do research on the extension of life does not turn out any product sold for profit in the short term.
As a researcher in the field of longevity Aubrey Gray explained to me: "People want to invest today to make money tomorrow.
With the extension of life, things take a while 'more time. "
But Elysium, with its supplements by $ 50 per month and its prestigious casket from Nobel, could show how the research on stretching of life can also pay off quickly.
It is still too early to tell, but the offer of the five winners of the Nobel Prize could be remembered as a turning point in the longevity market.

From Vice